title: Vemurafenib (PLX-4032)-induced keratoses: verrucous but not verrucae.
authors.forename: Christine J
authors.initials: CJ
authors.lastname: Ko
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: McNiff
authors.forename: Angelika
authors.initials: A
authors.lastname: Iftner
authors.forename: Thomas
authors.initials: T
authors.lastname: Iftner
authors.forename: Jennifer Nam
authors.initials: JN
authors.lastname: Choi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001707:Biopsy, Needle; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D007642:Keratosis / Q000139:chemically induced* / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D009362:Neoplasm Metastasis; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors*; D018570:Risk Assessment; D012871:Skin Diseases / Q000188:drug therapy / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077484:Vemurafenib; D014860:Warts / Q000139:chemically induced* / Q000473:pathology
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D048493:Proto-Oncogene Proteins B-raf